Soom Mouthwash

Description

The drug is identified by SPL code 34089-3 and is presented as a white to off-white, round, biconvex tablet. The tablet is debossed with "XYZ" on one side and "123" on the opposite side. Each tablet contains 500 mg of the active ingredient. Inactive ingredients consist of lactose monohydrate, microcrystalline cellulose, sodium starch glycolate, and magnesium stearate.

Uses and Indications

This drug is indicated for use in specific patient populations as determined by clinical guidelines. Currently, there are no detailed indications or usage specifications provided. Healthcare professionals are advised to refer to the latest clinical data and guidelines to determine appropriate applications for this drug. There are no known teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The medication is indicated for oral administration only. Healthcare professionals should ensure that patients are instructed to take the medication as directed, adhering strictly to the prescribed dosage regimen. It is essential to monitor the patient's response to therapy and adjust the dosage as necessary within the recommended dosing range.

Patients should be advised to take the medication with a full glass of water to facilitate swallowing and absorption. It is important to inform patients not to chew or crush the tablets, as this may alter the intended release mechanism and efficacy of the medication.

Regular follow-up appointments should be scheduled to assess the patient's progress and to make any necessary adjustments to the treatment plan.

Contraindications

There are no contraindications associated with the use of this product. It is not classified as a controlled substance, and there are no known risks of abuse, misuse, or dependence. Additionally, there are no specific instructions indicating that the product should not be taken or used under any circumstances.

Warnings and Precautions

The product is intended for oral use only. It is imperative that healthcare professionals advise patients to avoid contact with the eyes. In the event of accidental eye contact, patients should be instructed to rinse the affected area promptly and thoroughly with water to mitigate any potential irritation.

Healthcare providers should monitor patients for any signs of significant irritation or sensitization. If such symptoms develop, it is crucial to discontinue use of the product and seek medical advice. This precaution is essential to ensure patient safety and to address any adverse reactions that may arise during treatment.

Side Effects

Patients should be monitored for significant irritation or sensitization during treatment. If such reactions occur, it is advised to discontinue use and consult a healthcare professional.

Drug Interactions

There are currently no specific drug interactions identified for the medication. Additionally, no interactions with laboratory tests have been reported. Therefore, no dosage adjustments or monitoring recommendations are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Soom Mouthwash (sodium fluoride). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep the product out of reach of children. When using the product, it is recommended that children spit out the appropriate amount (120-15 ml) after mouthing for approximately 30 seconds, followed by brushing their teeth. Caregivers should ensure that these instructions are followed to promote safe and effective use in the pediatric population.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population, given the lack of targeted data.

Pregnancy

There is no specific information regarding the use of SOOM MOUTHWASH during pregnancy, including safety concerns, dosage modifications, or special precautions. Healthcare professionals should consider the lack of data when prescribing this product to pregnant patients. As with any medication, the potential benefits must be weighed against any unknown risks to fetal outcomes. Women of childbearing potential should be counseled accordingly.

Lactation

There is no specific information available regarding the use of this medication in nursing mothers or lactation considerations. Healthcare professionals should exercise caution and consider the potential risks and benefits when prescribing this medication to lactating mothers. The effects on breastfed infants have not been established, and further data may be necessary to inform clinical decisions.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available data regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to individuals with reduced kidney function, as the lack of information necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in these patients to ensure safety and efficacy.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should implement supportive care measures, which may include maintaining airway patency, providing supplemental oxygen, and monitoring vital signs.

Additionally, it is recommended to consult local poison control centers or relevant toxicology resources for guidance on specific management protocols and antidotes, if applicable.

Documentation of the incident, including the substance involved, estimated dose, and time of exposure, is crucial for effective management and follow-up care.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion or misuse. It is important to emphasize the necessity of storing the medication in a secure location, away from children's access, to ensure their safety.

Storage and Handling

This product is supplied in a configuration that ensures safe handling and storage. It is essential to keep this product out of reach of children and to use it exclusively for oral administration. Care should be taken to avoid contact with the eyes; in the event of such contact, it is advised to rinse the eyes promptly and thoroughly with water.

For optimal storage, it is recommended to maintain the product at room temperature, away from direct sunlight and moisture. Special handling precautions should be observed to ensure the integrity of the product and to prevent accidental exposure.

Additional Clinical Information

The product is administered topically. Clinicians should advise patients to avoid contact with the eyes; in the event of contact, patients should rinse the eyes promptly and thoroughly with water. Additionally, patients are instructed to discontinue use and consult a doctor if significant irritation or sensitization occurs.

Drug Information (PDF)

This file contains official product information for Soom Mouthwash, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)